Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey.
about
Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort studyPregabalin for the treatment of generalized anxiety disorder: an updateThe distribution of the common mental disorders: social inequalities in Europe.The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practiceAnxiety, Gambling Activity, and Neurocognition: A Dimensional Approach to a Non-Treatment-Seeking Sample.Long-term positive and negative psychological late effects for parents of childhood cancer survivors: a systematic reviewBeyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder.Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort studyCurrent evolutionary adaptiveness of psychiatric disorders: Fertility rates, parent-child relationship quality, and psychiatric disorders across the lifespanThe impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER studyThe risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study.A preliminary investigation of worry content in sexual minorities.Mental disorders in primary careCombined medication and cognitive therapy for generalized anxiety disorderTransdiagnostic dimensions of anxiety and depression moderate motivation-related brain networks during goal maintenance.Generalized anxiety disorder in primary care: mental health services use and treatment adequacyAN OPEN TRIAL OF EMOTION REGULATION THERAPY FOR GENERALIZED ANXIETY DISORDER AND COOCCURRING DEPRESSIONEffects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorderThe burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization.Testing the Short and Screener versions of the Social Adjustment Scale-Self-report (SAS-SR)A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorderCharacteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample.Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Characterization of Disability in Canadians with Mental Disorders Using an Abbreviated Version of a DSM-5 Emerging Measure: The 12-Item WHO Disability Assessment Schedule (WHODAS) 2.0.Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sampleA cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal.Increased error-related brain activity distinguishes generalized anxiety disorder with and without comorbid major depressive disorder.Is generalized anxiety disorder an anxiety or mood disorder? Considering multiple factors as we ponder the fate of GADTwo-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults.Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe.Childhood Trauma Associated with Enhanced High Frequency Band Powers and Induced Subjective Inattention of AdultsGeneralized anxiety disorder within the course of major depressive disorder: examining the utility of the DSM-IV hierarchy ruleRisk Factors, Clinical Presentations, and Functional Impairments for Generalized Anxiety Disorder in Military Personnel and the General Population in Canada.The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients.Emotion Regulation in Current and Remitted Depression: A Systematic Review and Meta-Analysis.Physical activity and sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease.
P2860
Q21260318-ECB546EA-F165-4040-85CA-3FFFC0EC4606Q24604809-9D948C35-3BD0-41F5-824A-D7CA390BCCB8Q24814389-C6470E57-4EDD-40BD-8F47-2BFE32C170BCQ30251737-17E30FAA-ED39-4541-817C-FB9F07F65850Q33551974-DA1F8906-D5D8-4130-A22B-267EB5245031Q33946044-A8179519-C0B1-4687-BB20-9BF67DDEEA41Q34024116-B87082EA-3269-4D54-B072-DE8AA83DF54AQ34094392-50B22CB0-0A90-4CA5-ABBC-A1AE70088F70Q34532410-13E65E1B-2B8F-4143-9510-3738F451F48FQ34536698-BAE7D471-EE42-484B-82E4-414FEBF16141Q34608546-6653128B-85AC-44A7-8AA9-914246069F61Q34988165-67A26F37-7791-433E-9090-5C5EE60636E2Q35236313-E70E66D0-D6FE-492D-95ED-98F9DD1E6620Q35377785-3C5B803A-4BE3-460B-8800-FDE5474D2D60Q35565893-B9BDB64D-6FBC-486C-A034-7032FC1016F5Q35817586-CFDDD4F1-6555-44F9-A5BF-F7961615F1A6Q35889453-308889D9-DE8C-4E76-91EB-3C722C61793FQ36115005-F9C3ABEA-A45A-4E8F-96AF-41C69215C533Q36127270-3616D0D4-EAAD-4AA3-9D45-DE5B428B1CAFQ36208542-78C19606-2073-4191-BA10-4A3F2E5FF0B4Q36366194-F460CD5E-5C64-4C1E-9BAD-955907236084Q36577463-2C03E732-24A5-43BC-B2D3-B6376C73C252Q36612447-258E0172-8E6F-422E-8226-40E530A432E9Q36694888-D875DA10-2638-4411-B61C-9E602D110D9DQ36776669-7060D1F8-4ADE-40CC-8D2A-6E7DA72378B2Q36797810-E4E41D25-5E28-4E59-A502-234E21108A9FQ36859855-0CD4FF90-681F-4E86-B434-F8AF7A1B1273Q37432545-E2871423-4DF6-4CD9-A0E8-35367C2DA1F5Q37633180-955C738E-F42F-49C9-A5FD-54EE840ACF47Q38817470-1C88F8CD-A731-4644-8CCB-98D198221D3AQ38905913-D46E5D26-19BD-43AD-9D9B-63D3F851DCC6Q41436259-F5D44276-EF38-4E76-9D94-B07B981B96EFQ42256746-A81589A0-1984-49EC-AD01-D748F7920DE1Q47179443-F0E94ED3-D8A2-43B1-98CD-29136913EB5CQ49348734-C524DEA0-82AF-484B-8F48-99653CF10CB1Q55384029-A21DE832-C196-4B66-B9DD-2F570CF02A57Q55460810-A8B50C01-FFA3-465C-AEDC-C80891A95DCC
P2860
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Disabilities and quality of li ...... pression in a national survey.
@en
Disabilities and quality of li ...... pression in a national survey.
@nl
type
label
Disabilities and quality of li ...... pression in a national survey.
@en
Disabilities and quality of li ...... pression in a national survey.
@nl
prefLabel
Disabilities and quality of li ...... pression in a national survey.
@en
Disabilities and quality of li ...... pression in a national survey.
@nl
P2093
P1476
Disabilities and quality of li ...... epression in a national survey
@en
P2093
R C Kessler
R M Carter
S A Montgomery
P304
P356
10.1097/00004850-200015060-00002
P577
2000-11-01T00:00:00Z